Company Filing History:
Years Active: 1983-1995
Title: The Innovations of Christopher B Chapleo
Introduction
Christopher B Chapleo is a notable inventor based in Swanland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and depression. With a total of four patents to his name, Chapleo's work reflects a commitment to advancing medical science.
Latest Patents
Chapleo's latest patents include innovative compounds such as imidazolinyl indole derivatives that are useful in the treatment of diabetes. He has also developed an imidazoline derivative and a method for treating depression. One of his notable inventions is the compound 2-[2-(1,4-Benzodioxanyl)]-2-imidazoline, which is characterized by its unique nuclear magnetic resonance spectrum. This compound is designed to be substantially free of 2-[2-(2-methyl-1,3-benzodioxyl)]-2-imidazoline, ensuring its efficacy and safety. Additionally, he has worked on processes for the preparation of these compounds and their use as presynaptic α2-adrenoreceptor antagonists.
Career Highlights
Chapleo is associated with Reckitt & Colman Products Limited, where he has been able to apply his innovative ideas in a corporate setting. His work has not only contributed to the company's portfolio but has also advanced the field of pharmaceutical research.
Collaborations
Throughout his career, Chapleo has collaborated with notable colleagues such as Peter L Myers and Gay P Fagan. These collaborations have likely enriched his research and contributed to the successful development of his patents.
Conclusion
Christopher B Chapleo's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the treatment of diabetes and depression, showcasing the importance of innovation in medicine.